CVS prescription-drug plan costs more at stores selling tobacco

CVS Health is using its tobacco-free policy as a way to one-up rivals. The chain's pharmacy benefits unit is offering a prescription-drug plan that charges patients more if they buy their meds at drugstores that sell tobacco products, according to Wall Street Journal.

The plan features copayments that are up to $15 higher on prescriptions filled where tobacco is sold--giving people clear incentive to buy their medications at CVS.

Read more below:

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.